Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need (Bio Space)
UF startup Kriya Therapeutics, Inc., a clinical-stage biopharmaceutical company developing gene therapies to address common chronic diseases of high unmet need, announced the closing of a $320 million Series D financing.